Keystone Symposia

This meeting took place in 2018

Here are the related meetings in 2021:
Antibodies and Vaccines as Drugs for COVID-19 (EK31)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Antibodies as Drugs: Translating Molecules into Treatments (C1)

Organizer(s) Paul W. H. I. Parren and Erica Ollmann Saphire
February 25—March 1, 2018
Whistler Conference Centre • Whistler, BC Canada
Discounted Abstract Deadline: Oct 24, 2017
Abstract Deadline: Nov 21, 2017
Scholarship Deadline: Oct 24, 2017
Discounted Registration Deadline: Dec 19, 2017

Sponsored by Bioverativ Therapeutics, Genentech, Inc., ImmunoGen, Inc., Merck & Co., Inc., OncoMed Pharmaceuticals, Inc., Pfizer Inc. and Regeneron Pharmaceuticals, Inc.

Summary of Meeting:
Antibodies carry an enormous potential in prophylaxis and treatment of human disease. Antibody therapies may be divided into two distinct but highly related disciplines. First, antibodies can be elicited de novo using vaccines. Our understanding of what constitutes an effective antibody response at the molecular level and the science of eliciting such antibodies in vivo are progressing rapidly. Secondly, isolated antibodies represent powerful drugs when developed as biopharmaceuticals, as demonstrated by the ever-expanding list of approved molecules as well as by the large number of antibody products in development in a wide range of therapeutic areas. The antibody landscape is changing as the field has moved from empirical to knowledge-based, designer approaches for which understanding of mechanisms of action at the molecular level is critical. Translating such basic knowledge into novel products and applications requires scientists from many disciplines including structural and cellular immunology, biology, engineering, chemistry and medicine to interact closely. Consequently, the field of antibody-based vaccines and therapeutics has become an interface area where experts meet and work together. The 2018 Keystone Symposia antibodies conference aims to provide a platform for knowledge-sharing from the molecular to the systems level to navigate the newest developments and insights to prevent, treat and cure major human diseases.

View Meeting Program


National Institute of Allergy and Infectious Diseases (NIAID) Scholarship Recipients

Arthur S. Kim
Washington University School of Medicine, USA

Kalie Mix
Sanofi, USA

The Antibody Society Scholarship Recipients

Jeffrey J. Bunker
University of Chicago, USA

Philipp Leonhard Kolb
University of Freiburg, Germany

Maria Mar Naranjo
Centre National de la Recherche Scientifique, France

Seline Zwarthoff
University Medical Center Utrecht, Netherlands